SCHEMBL1382098

SCHEMBL1382098

O[C@H](COc1ccc(-c2onc3cc(F)ccc23)cc1)CN1CCC(Oc2cccc(Cl)c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 4/20 0.50
CCR3 P51677 4/20 0.50
DRD2 P14416 5/20 0.49
DRD4 P21917 4/20 0.49
CACNA1G O43497 4/20 0.49
DRD3 P35462 3/20 0.49
USP2 O75604 1/20 0.46
HTR2A P28223 2/20 0.45
HTR1A P08908 1/20 0.45
TSHR P16473 1/20 0.44
RECQL P46063 1/20 0.43
KCNH2 Q12809 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7567332 1.00 HRH1 (0.50) HRH1CCR3DRD2DRD4CACNA1G
SCHEMBL7567340 1.00 HRH1 (0.50) HRH1CCR3DRD2DRD4CACNA1G
SCHEMBL5360231 0.86 DRD2 (0.52) HRH1CCR3DRD2DRD4CACNA1G
SCHEMBL5367345 0.86 DRD2 (0.52) HRH1CCR3DRD2DRD4CACNA1G
SCHEMBL5360233 0.86 DRD2 (0.52) HRH1CCR3DRD2DRD4CACNA1G
SCHEMBL7497905 0.83 HTR2A (0.51) DRD2USP2HTR2AHTR1ATSHR
SCHEMBL7500542 0.83 HTR2A (0.51) DRD2USP2HTR2AHTR1ATSHR
SCHEMBL5360652 0.81 DRD2 (0.48) HRH1CCR3DRD2DRD4CACNA1G
SCHEMBL5360657 0.81 DRD2 (0.48) HRH1CCR3DRD2DRD4CACNA1G
SCHEMBL7496035 0.80 HTR2A (0.69) HRH1DRD2DRD3HTR2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4806149-B2 2011-11-02 JP claimed
EP-1216244-A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists Aventis Pharmaceuticals Inc. (US) 2002-06-26 EP claimed
WO-2001019821-A1 BENZISOXAZOLYL-, PYRIDOISOXAZOLYL- AND BENZTHIENYL-PHENOXY DERIVATIVES USEFUL AS D4 ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2001-03-22 WO claimed